Bone marrow transplantation for inherited bone marrow failure syndromes

Parinda Mehta, Franco Locatelli, Jan Stary, Franklin O. Smith

Research output: Contribution to journalArticlepeer-review


The inherited bone marrow failure (BMF) syndromes are characterized by impaired hematopoiesis and cancer predisposition. Most inherited BMF syndromes are also associated with a range of congenital anomalies. Progress in improving the outcomes for children with inherited BMF syndromes has been limited by the rarity of these disorders, as well as disease-specific genetic, molecular, cellular, and clinical characteristics that increase the risks of complications associated with hematopoietic stem cell transplantation (HSCT). As a result, the ability to develop innovative transplant approaches to circumvent these problems has been limited. Recent progress has been made, as best evidenced in studies adding fludarabine to the preparative regimen for children undergoing unrelated donor HSCT for Fanconi anemia. The rarity of these diseases coupled with the far more likely incremental improvements that will result from ongoing research will require prospective international clinical trials to improve the outcome for these children.

Original languageEnglish
Pages (from-to)147-170
Number of pages24
JournalPediatric Clinics of North America
Issue number1
Publication statusPublished - Feb 2010


  • Bone marrow transplantation
  • Diagnostic tests
  • Gene mutation
  • Inherited bone marrow failure syndromes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Bone marrow transplantation for inherited bone marrow failure syndromes'. Together they form a unique fingerprint.

Cite this